Bayer files suit against Watson over birth control pill patent
The lawsuit seeks to prevent Watson from commercializing its product prior to the expiration US patent number 6,441,168. Watson Pharmaceuticals has confirmed that Watson Laboratories has filed an
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.